Menu
Recruiting NCT07097298

Empathy and (Self-)Compassion in Parkinson's Disease Patients and Caregivers

No phase Interventional Parkinson Disease(PD)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: empathy and compassion training.
Who it may be relevant to
Registry conditions: Parkinson Disease(PD). Basic parameters: 50 years — 80 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Switzerland
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Empathy and (Self-)Compassion to Improve the Quality of Life of Parkinson's Disease Patients and Caregivers: an Exploratory Study

Overview

The goal of this clinical trial is to improve quality of life in Parkinson's Disease (PD) patients by increasing their empathy and their (self-)compassion. The main question it aims to answer is: Does the level of quality of life in PD patients and caregivers improve after empathy/(self-)compassion training? Participants will be delivered a 6-week empathy and compassion training (mindfulness, writing and poetry exercises addressing the cognitive, emotional, motivational and behavioural components of (self-)compassion) and will also be asked to answer questionnaires before and after the training

Interventions

  • Behavioral empathy and compassion training
    A 6-week empathy and compassion training will be designed and delivered involving PD patients and caregivers. During the compassion training participants will do mindfulness, writing and poetry exercises

Primary outcome measures

  • PD patients quality of life improvement [Time frame: from baseline to the end of intervention (6weeks)]
Secondary outcome measures (4)
  • change in the level of empathy in PD patients and caregivers [Time frame: from baseline to the end of intervention (6weeks)]
  • self-compassion level change in PD patients and caregivers [Time frame: from baseline to the end of intervention (6weeks)]
  • compassion level change in PD patients and caregivers [Time frame: from baseline to the end of intervention (6weeks)]
  • quality of life level change in caregivers [Time frame: from baseline to the end of intervention (6weeks)]

Eligibility criteria

Inclusion criteria

  • Diagnosis of PD
  • Hoehn and Yahr scale, stage ≤ 3
  • Mini Mental State Examination with a score ≥ 26
  • Able to give informed consent as documented by signature
  • At least, secondary school education
  • To have a regular caregiver at home

Exclusion criteria

  • Any medical condition that is not PD, such as drug induced parkinsonism
  • Major depression, dysthymia, or according to DSM-V
  • Other neurological or psychiatric diseases
  • Neuropsychological scores compatible with the diagnosis of early dementia
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, etc

For CAREGIVERS:

Inclusion criteria

  • Taking care of the patient on a regular basis, i.e., at least 3 days per week
  • Being caregiver of the patients for at least 3 months
  • At least, secondary school education
  • Written informed consent

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Supportive care

Study locations

Switzerland · 1 center
  • Istituto di Neuroscienze Cliniche della Svizzera Italiana, EOC — Lugano

Identifiers

NCT: NCT07097298 · EMPCOMP-PD-001

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗